RSD1235

· Astellas Pharma Inc

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for RSD1235, covering 2007-12-24 to 2008-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Study of RSD1235 to Evaluate Safety in Patients With Atrial Fibrillation [Phase 3]